PepsiCo’s strong track record of consecutive quarterly beats, combined with consensus estimates calling for modest core EPS growth to $2.30 from $2.29 year-over-year on revenue of roughly $24.96 billion, underpins the 71% market-implied probability of a Q3 2026 beat. Traders are pricing in continued international momentum and pricing discipline to offset persistent North American volume softness and margin pressure from higher input costs and GLP-1 medication effects. Recent analyst revisions have been modest, with EPS forecasts holding near $2.30 over the past month despite some downward drift over 90 days, while options markets have implied a contained post-print move. The October 8 release serves as the immediate catalyst, with any outperformance in organic revenue or operating margins likely reinforcing the current trader consensus.